31.49
+0.09(+0.29%)
Currency In USD
| Previous Close | 31.4 |
| Open | 31.4 |
| Day High | 32.53 |
| Day Low | 31.2 |
| 52-Week High | 32.71 |
| 52-Week Low | 8.89 |
| Volume | 633,577 |
| Average Volume | 770,432 |
| Market Cap | 1.39B |
| PE | -16.23 |
| EPS | -1.94 |
| Moving Average 50 Days | 28.76 |
| Moving Average 200 Days | 19.48 |
| Change | 0.09 |
If you invested $1000 in Beta Bionics, Inc. (BBNX) since IPO date, it would be worth $1,332.63 as of January 08, 2026 at a share price of $31.49. Whereas If you bought $1000 worth of Beta Bionics, Inc. (BBNX) shares 6 months ago, it would be worth $2,358.8 as of January 08, 2026 at a share price of $31.49.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
GlobeNewswire Inc.
Dec 08, 2025 12:45 PM GMT
IRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) (the “Company”), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to pre-release its topline fourth q
Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
GlobeNewswire Inc.
Oct 09, 2025 12:00 PM GMT
IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2025 financial results
Beta Bionics Announces Participation at Upcoming Investor Conferences
GlobeNewswire Inc.
Aug 21, 2025 12:00 PM GMT
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at three upcoming investor conferenc